Effects of intake of a test food on postprandial blood triglyceride level -a randomized, double blind placebo-controlled, cross-over study-

Effects of intake of a test food on postprandial blood triglyceride level -a randomized, double blind placebo-controlled, cross-over study- - Effects of a test food on postprandial blood triglyceride level

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000037160

Enrollment

Registered

2019-07-02

Start date

2019-06-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult (who has fasting blood triglyceride level less than 150 mg/dl)

Interventions

Single ingestion of the placebo food - washout period (more than 6 days) - single ingestion of the test food Single ingestion of the placebo food - washout period (more than 6 days) - single ingestion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Healthy subjects aged 20 to 64 years old. (2) Subjects whose fasting serum triglyceride levels are less than 150 mg/dL in medical check up within 1 year (3) Subjects who gave written informed consent.

Exclusion criteria

Exclusion criteria: a. Subjects who have a history of treatment for malignancy, heart failure and myocardial infarction b. Subjects who have been treated for the following chronic diseases: atrial fibrillation, arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes, dyslipidemia, hypertension, etc. c. Subjects who frequently use oral medication and/or supplements and/or functional foods (include traditional Chinese medicine) could affect lipid metabolism. d. Subjects who have allergy (medical products, test food related food) e. Subjects who are planned to get pregnant after informed consent for the current study or are pregnant or breastfeeding. f. Subjects who are judged as unsuitable for the study by the physician in charge for other reason.

Design outcomes

Primary

Measure	Time frame
The differences of serum triglyceride level at sequential sampling time point and AUC (area under the blood concentration - time curve)	—

Secondary

Measure	Time frame
The change of serum RLP cholesterol level at sequential sampling time point and AUC Other lipid metabolism related factors (total cholesterol, LDL-cholesterol, HDL-cholesterol, free fatty acid, lipoprotein (a,b), lipoprotein fraction (HDL, LDL, VLDL), phospholipid)	—

Countries

Japan

Contacts

Public ContactHiroaki Yamada

Pharma Foods International Co., Ltd. R&D department

h-yamada@pharmafoods.co.jp0753948605

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026